Status:

COMPLETED

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

Lead Sponsor:

Tibotec Pharmaceuticals, Ireland

Conditions:

HIV Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The primary objective of the TMC114-C215 study is to evaluate the safety and tolerability of TMC114/RTV over time. The secondary objectives are to evaluate the antiviral activity over time and to eval...

Detailed Description

The study will continue for 144 weeks after study medication has begun. For patients failing treatment, they must have participated in the TMC114-C213 or TMC114-C202 for at least 12 weeks and meet spe...

Eligibility Criteria

Inclusion

  • Previous participation in the TMC114-C202 or TMC114-C213 trials
  • Significant virologic failure during participation in the above trials
  • Study participation in the treatment phase of the original trial for a total of at least 12 weeks before TMC114-C215 screening
  • Patient agrees to take TMC114/RTV with at least 2 other antiretrovirals (NRTIs), with or without T-20, from baseline onwards
  • Patient has given informed consent

Exclusion

  • Use of disallowed concomitant therapy
  • Patient with clinical or laboratory evidence of active liver disease, liver impairment/ dysfunction or cirrhosis irrespective of liver enzyme levels
  • Any active or unstable medical condition that, in the investigator's opinion, would compromise the subject's safety
  • Patient with laboratory abnormalities at screening as defined by ACTG grading scheme as listed in the protocol
  • Patient withdrawing consent from TMC114-C202 or TMC114-C213

Key Trial Info

Start Date :

November 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

555 Patients enrolled

Trial Details

Trial ID

NCT00081588

Start Date

November 1 2003

End Date

December 1 2008

Last Update

June 20 2014

Active Locations (64)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 16 (64 locations)

1

Birmingham, Alabama, United States

2

Beverly Hills, California, United States

3

La Jolla, California, United States

4

Long Beach, California, United States